Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-fluorouracil cream for cervical precancer in women with HIV
NCT05413811Completed
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Mar 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in cervical intraepithelial neoplasia (CIN) comparing 5 Fluorouracil (5FU) Cream with Placebo Cream (2 arms). Primary endpoints: Number of Participants Retained in the Study at 24 weeks, Number of Participants With >=80% Acceptability Summary Score at 24 weeks and 3 more. Started Mar 2023; status: completed.
02
Drugs
fluorouracil
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT05413811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05413811.